Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q-Free: Second quarter 2021 results

(Oslo, 9 July 2021) Q-Free ASA (OSE: QFR) reported revenues of NOK 253 million (223) in the second quarter of 2021 and an EBITDA of NOK 35 million (26). The company has a backlog of NOK 1.2 billion and reiterates its positive short- and long-term outlook. “Performance in the second quarter was very strong with high organic revenue growth and significantly improved profitability. Both Tolling and Traffic Management contributed to the best quarterly results since 2017,” says Håkon Volldal, President and CEO of Q-Free. In the second quarter of 2021 Q-Free generated revenues of NOK 253

Mercell uplisted to the Oslo Stock Exchange

· Mercell – the Nordic market leader in digital public tendering – is today uplisted from the Euronext Growth trading platform to the main list on the Oslo Stock Exchange (OSE) · Mercell’s uplisting is expected to increase visibility in the marketplace, improve liquidity and broaden the shareholder base and ultimately enhance value for all stakeholders · Mercell is well positioned to fulfil its strategic growth ambitions which is to more than double its annual recurring revenues in existing markets over the next five years · Mercell’s vision is to become the preferred e-tendering

Vitrolife completes a directed share issue of 9.6 million shares, raising proceeds of approximately SEK 3.6 billion

Vitrolife AB (publ) (“Vitrolife”) has, based on the authorisation granted by the annual general meeting on 28 April 2021 and in accordance with what Vitrolife indicated in a press release on 8 July 2021, resolved to carry out a directed share issue of 9,645,303 shares at a subscription price of SEK 368.92 per share. The subscription price has been determined through an accelerated book building procedure.Vitrolife announced yesterday the signing of the acquisition of Igenomix S.L.[1] (“Igenomix”) and Vitrolife intends to partly finance this acquisition with the proceeds from the directed

Conference call regarding the acquisition of Igenomix

Invitation to attend Vitrolife’s conference call regarding the acquisition of Igenomix. The presentation will be held in English.Time: Friday 9 July, 2021 at 10.00 a.m. CET.Registration can preferably be done 10-15 minutes before the conference start time on:Sweden dial in number: +46 (0)8 566 184 67International dial in number: +44 (0) 2071 928338Conference name: Vitrolife, conference ID: 5694413Vitrolife participants:Thomas Axelsson, CEOMikael Engblom, CFO Before the conference call, presentation material will be available at the company web page, https://www.vitrolife.

Nyfosa Finland acquires property portfolio in Finland at a value of SEK 2.1 billion

2021-07-08Nyfosa has acquired a portfolio consisting of nine office properties and one project property in the Finnish university town of Jyväskylä at a total value of MEUR 208, corresponding to approximately SEK 2.1 billion. The acquisition creates a solid platform for continued growth. Seller is Castellum.The portfolio, which was part of the recent Castellum acquisition from Brunswick Real Estate and Blackstone Tactical Opportunities consists of modern and sustainable office properties is centrally located in the expansive regional city of Jyväskylä, Finland's fifth largest city with

Scandinavian ChemoTech starts a feasibility study in the USA

Today Scandinavian ChemoTech has signed an agreement with the US based company Diversified Consultant Group LLC that will be responsible for performing a feasibility study. This study is aiming to identify how Scandinavian ChemoTech should design a “Go-to-Market” strategy when launching its animal care product vetIQure in the USA.The US market for vetIQure is of great significance as the Cancer therapy market for pets is estimated to over MUSD 800/y and growing with a double-digit rate. Diversified Consultant Group LLC was founded by the CEO Danny Nesrallah, who has extensive experience

Nyfosa acquires property portfolio in Finland at a value of MDSEK 2.1

Nyfosa has acquired a portfolio consisting of nine office properties and one project property in the Finnish university town of Jyväskylä at a total value of MEUR 208, corresponding to approximately MDSEK 2.1. The acquisition creates a solid platform for continued growth. Seller is Castellum.The portfolio of modern and sustainable office properties is centrally located in the expansive regional city of Jyväskylä, Finland's fifth largest city with two of the country's larger universities. The properties have a total area of 67 thousand square meters with an annual rental income of

12 Quiet, Uncrowded Beach Retreats in California

SACRAMENTO, CA [July 8, 2021]—Hundreds of beaches stretch along California’s 840 miles of coastline. While many of the state’s beaches attract throngs of tourists, there are still lesser-known swaths of sand to be found. The California Association of Boutique & Breakfast Inns  (CABBI) has compiled a list of under-the-radar beach retreats for travelers seeking solitude by the sea.Elk Cove Inn & SpaThe population of Elk, California hovers just above 200, making it an ideal destination for a secluded beach getaway. Perched on a bluff overlooking Greenwood State Beach

Castellum divests its property portfolio in Jyväskylä to Nyfosa for SEK 2.1 billion

Castellum recently acquired a Finnish property portfolio through its acquisition of Kielo. Nine properties from the portfolio, located in Jyväskylä, are now being divested to Nyfosa for SEK 2.1 billion.“The divestment is a geographic focusing of the Finnish portfolio. We are continuing our journey of growth, building an even stronger Nordic platform for sustainable, high-quality office and logistics properties,” says Henrik Saxborn, CEO of Castellum AB. The divestment comprises nine office properties and one building right, attractively located in the regional city of Jyväskylä. The

TOMRA Deploy 3DEXPERIENCE with TECHNIA

Eindhoven, Netherlands TECHNIA, the #1 knowledge leaders in PLM and Engineering, announced today a milestone in their strategic partnership with TOMRA Food – the world’s leading manufacturer of sensor-based sorting solutions for the food industries.TOMRA Food   is a multinational corporation, working to provide sorting solutions for resource optimization. They have more than 50 years of experience in sorting, providing highly innovative sensor-based solutions that help their customers to obtain more, use less and reuse resources to help make the planet

EQT Private Equity to sell Igenomix to Vitrolife for an enterprise value of EUR 1.25 billion

· Igenomix is a global leader in molecular genetic diagnostics for reproductive medicine and rare diseases - assisting approximately 90,000 patients per year through a diversified portfolio of in vitro fertilization (IVF) and rare diseases genetic testing services · The combination of Igenomix and Vitrolife will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services  · As part of the transaction, EQT Private Equity will become a

Vitrolife intends to carry out a directed share issue

Vitrolife AB (publ) (“Vitrolife”) has mandated Skandinaviska Enskilda Banken (“SEB”) to evaluate the conditions for carrying out a directed share issue corresponding to a value of approximately SEK 3.6 billion, through an accelerated book building procedure, based on the authorisation granted to the board of directors on the annual general meeting on 28 April 2021. The directed share issue is fully covered by subscription commitments from a number of current shareholders and new investors.Proceeds received from the directed share issue will be used to partly finance the acquisition of

Trading update for the second quarter

In regard to the acquisition of Igenomix and the subsequent directed share issue, Vitrolife is presenting sales and preliminary income for the second quarter.Second quarter · Sales amounted to SEK 382 (209) million, corresponding to an increase of 83 percent in SEK. Sales increased by 94 percent in local currency. · The preliminary operating income before depreciation and amortisation (EBITDA) amounted to SEK 134 (40) million, corresponding to a margin of 35 (19) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 15 million. The operating income included non-

Vitrolife acquires Igenomix and creates a global leader in reproductive health

Vitrolife AB (publ) (“Vitrolife”) has entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.[1] (“Igenomix”) from EQT and other shareholders (together the “Sellers”). The combination will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services.Igenomix – a global leader in reproductive genetic testing services Igenomix is a global leader in women’s health and reproductive genetic testing services for IVF clinics

NPRO: Key information relating to the cash dividend to be paid by Norwegian Property ASA

Dividend amount: NOK 0.10 per share Last day including right: 12[th] July 2021 Ex-date: 13[th] July 2021 Record date: 14[th] July 2021 Payment date: 11[th] August 2021   For additional information, please contact: Bent Oustad, CEO, tel. +47 4801 6082, e-mail: bo@npro.noHaavard Rønning, CFO, tel. +47 400 200 19, e-mail: hr@npro.no This information is subject of the disclosure requirements according to §5-12 of the Norwegian Securities Trading Act (’Verdipapirhandelloven’).

NPRO: 2Q 2021 – Increased rental income and acquisition of Felix conference centre at Aker Brygge

Norwegian Property presents the results for Q2-2021 on 9[th] July at 08:30. Due to infection control it will only be possible to follow the presentation in Norwegian on the webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20210709_1/ The net profit for the second quarter was NOK 175.8 million. This resulted in second-quarter earnings per share (EPS) of NOK 0.27. The book value of equity per share as at 30 June 2021 was NOK 18.53. The rental income amounted to NOK 228.6 million for the second quarter, up from NOK 172 million in the corresponding period of 2020. A

Mangold Insight has presented an analysis of Smoltek

Mangold Insight has today presented its first analysis in the monitoring of Smoltek Nanotech Holding AB (publ).Fund brokerage firm Mangold has initiated a monitoring of Smoltek and today presents an analysis where they state, among other things, that Smoltek is in an early commercialization phase of the capacitor technology CNF-MIM, which enables extremely thin high-performance capacitors in semiconductors, and that Smoltek has now also broadened its market outside the semiconductor industry by identifying other sectors where the company's patent-protected technology platform can create

#21-231 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-230 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

SOTKAMO SILVER AB: Q2/2021 RELEASE AND WEB CAST

Press release: Stockholm, July 8, 2021, 16:30 CETSotkamo Silver AB will release Q2/2021 results on July 15, 2021, around 08:45 CET. The webcast to the investors will be held on July 15, 2021, at 10:00 Finnish time via a Teams-meeting. You can register for the meeting on the company's website at: www.silver.fi/fi/sijoittajat/ilmoittaudu  We will send registration instructions and a link to the event to those who have registered before the event. Please, make your registration by July 14, 2021. The presentation will be in Finnish, and the material is in English. The presentation

Invitation to presentation of Nordic Paper’s interim report Q2 2021

Nordic Paper’s interim report for the second quarter 2021 will be published on Tuesday 20 July at 07.30 CEST. Nordic Paper’s CEO Anita Sjölander and CFO Niclas Eriksson will present the report via an audiocasted telephone conference on the same day at 10:00 CEST. The presentation will be held in English and will be followed by a Q&A session. The presentation can be followed on:https://onlinexperiences.com/Launch/QReg/ShowUUID=DD23E1E0-953B-4D38-8DF2-F1653C00927A&LangLocaleID=1033 To participate via telephone and thereby be able to ask questions, please use any of the following

CORRECTION: Nurminen Logistics Plc: Estimated entry date of the new shares in the Trade Register

Nurminen Logistics Plc                            Stock Exchange Release July 8, 2021, at 5.00 p.m.   Correction to the stock exchange release issued by Nurminen Logistics Plc (the “Company”) on June 7, 2021, at 3:00 p.m. In the release, the assessment is based on the information received from the Finnish Patent And Registration Office at the moment that the new shares would be entered in the Trade Register by June 25 — 28, 2021. The new estimate is that the shares will be entered in the Trade Register as of July 13, 2021, after which the Company will immediately apply for the shares

The Board of Directors of DanCann Pharma A/S convenes an Extraordinary General Meeting and proposes that the Meeting resolves a directed share issue

The Board of Directors of DanCann Pharma A/S (publ) (“DanCann Pharma” or “the Company”) has today decided to convene an Extraordinary General Meeting of the Company on 23 July 2021 and proposes that the Board of Directors have the mandate to resolve a directed issue. Notice of the Extraordinary General Meeting is published and attached in this press release.The CEO of DanCann Pharma, Jeppe Krog Rasmussen, comments: I am pleased to announce that we in close contact with close parties and investors in DanCann Pharma today call for an Extraordinary General Meeting due to the proposal to

Electrolux to acquire French service provider La Compagnie du SAV (CSAV)

With the acquisition Electrolux, a leading global appliance company, strengthens its service network in France and underlines its commitment to drive circularity and the repairability of appliances.Electrolux today announced it has agreed to acquire La Compagnie du SAV (CSAV), the main French independent service provider (ISP) specialized in repairing domestic appliances. The acquisition is fully in line with the Electrolux Group strategy to offer outstanding experiences to consumers, ensuring they get the most out of their appliances during the complete lifecycle of the product. “With

There are no items matching the current filter
There are no more items matching the current filter
Back to top